Dear Editor, The cytogenetic hallmark of chronic myeloid leukemia (CML) is the Philadelphia chromosome (Ph), the consequence of the reciprocal translocation t(9;22)(q34;q11.2) that results in the BCR-ABL1 fusion gene, located in the Ph chromosome [1] . The natural history of untreated CML is an initial indolent chronic phase which is followed by a blast phase either suddenly or through an accelerated phase. Blast crisis may be diagnosed when blast cells are ≥20% of the peripheral blood WBC or the nucleated cells of the bone marrow or when there is an extramedullary blast proliferation [1, 2] . In approximately 70% of cases the blast lineage is myeloid while in 20-30% of cases the blasts are lymphoblasts [1, 2] . Progression is usually associated with clonal evolution, and at the time of transformation to blast crisis, 80% of patients demonstrate cytogenetic changes in addition to the Ph chromosome such as an extra Ph chromosome, +8, i(17q), +19, t(3;21)(q26;q22), and very rarely t(7;11)(p15;p15) [3] .
Plasma cell leukemia (PCL) is an aggressive and rare hematological malignancy which is characterized by circulating plasma cells >2×10 9 /l in peripheral blood or by a plasmatocytosis >20% of blood leukocytes and confers a poor prognosis. It originates as a primary disease or as a secondary leukemic transformation of multiple myeloma [4] . The most frequent features at diagnosis are asthenia, severe anemia, thrombocytopenia, splenomegaly, or hepatomegaly while CD38 and CD138 antigens are excellent plasma cell markers [5, 6] . In the majority of the cases, karyotypes are complex and hypodiploid or pseudodiploid. Common chromosome abnormalities are 14q32 translocations such as t(11;14)(q13;q32), t(4;14)(p16.3;q32), t(14;16)(q32;q23), deletions of the chromosomal regions 17p13, 13q, and 1p21, monosomies of chromosomes 13 and X (in women), trisomy 18, amplification of 1q21, and MYC rearrangements [4] [5] [6] [7] .
Here, we report for the first time a rapidly fatal case of a PCL crisis in a young patient with Ph chromosome-positive CML.
The patient, a 43-year-old male with a 2-month history of persistent fatigue, weakness, and loss of weight was admitted to our department. On physical examination spleen was remarkably enlarged and routine complete blood count revealed leukocytosis with a WBC of 22× 10 9 /l, anemia with a Hb of 7 gr/dl, and thrombocytopenia with platelet count of 30×10 9 /l. Neither hypercalcemia nor proteinuria was observed. Blood smear showed 90% blasts with the appearance of plasma blasts (Fig. 1) . Immunophenotyping of blast cells by flow cytometry showed CD45+ (79%), CD38+ (77%), CD34+ (56%), surface κ(−), surface λ(-), cytoplasmic κ+ (90%), cytoplasmic λ(−), and CD20 (−). The cytogenetic analysis of G-banded chromosomes in peripheral blood cells revealed two evolutionary clones, which were positive for Ph chromosome. The karyotype was described as: 46,XY,t(9;22)(q34;q11.2) [4] /32,XY,-2, -3,-4,-5,t(9;22)(q34;q11.2),-10,-11,-12,-13,-15,-16,-17,-18, -20,-22 [16] . Unfortunately, the patient developed acute renal failure on the second day after admission and died 2 days later.
Ph chromosome and/or BCR-ABL1 fusion gene which are detected in 90-95% of cases of CML is used as a major criterion for diagnosis of CML [1, 2] . Ph chromosome, marked splenic enlargement, thrombocytopenia, and the high percentage of blasts are compatible with the diagnosis of blast crisis of CML. It seems possible that our patient suffered from nondiagnosed CML and presented at the time of blast crisis, which turned to be a plasmablastic leukemia. This hypothesis relies on the cytogenetic and immunophenotypic analysis of the leukemic cells. Two related clones were detected in our patient. The first clone was characterized only by t(9;22)(q34;q11.2), indicating that Ph chromosome was the primary aberration, possibly created in the chronic phase of CML. The evolutionary clone showed severe hypodiploidy, including monosomy 13 and chromosome aberrations different from that of the blast crisis of CML, in addition to t(9;22)(q34;q11.2). Severe hypodiploid karyotype and monosomy 13 are common cytogenetic features of plasma cell leukemia. Positivity for CD38 and cytoplasmic kappa light chain revealed by immunophenotypic analysis of the leukemic cells, confirmed the plasmacytic origin of blasts. Therefore, the most likely diagnosis of our patient is that of plasmablastic crisis of Philadelphia chromosome-positive CML. To the best of our knowledge, this case presents the first reported case of plasmablastic crisis of Ph chromosome-positive CML.
